Our Portfolio

Accelerating Innovation
FDA Drug Approvals

Patients are waiting. Biopharma’s essence is delivering innovative medicines to patients with major unmet needs. Management, scientists, clinical investigators, and investors all together strive towards that shared goal. Today, the biotech renaissance is in full swing. This is the time to invest. The global convergence of biological and chemical insights, life science technology, data analytics, talent and capital is unprecedented.



For general inquiries please contact us at: info@ascentacap.com